|
1
|
National Nosocomial Infections
Surveillance System: National Nosocomial Infections Surveillance
(NNIS) System Report, data summary from January 1992 to June 2002,
issued August 2002. Am J Infect Control. 30:458–475. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Selvey LA, Whitby M and Johnson B:
Nosocomial methicillin-resistant Staphylococcus aureus
bacteremia: Is it any worse than nosocomial methicillin-sensitive
Staphylococcus aureus bacteremia? Infect Control Hosp
Epidemiol. 21:645–648. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
López-Cortés LE, Gálvez-Acebal J, Del Toro
MD, Velasco C, de Cueto M, Caballero FJ, Muniain MA, Pascual A and
Rodríguez-Baño J: Effect of statin therapy in the outcome of
bloodstream infections due to Staphylococcus aureus: A
prospective cohort study. PLoS One. 8:e829582013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lowy FD: Staphylococcus aureus
infections. N Engl J Med. 339:520–532. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
DeLeo FR, Otto M, Kreiswirth BN and
Chambers HF: Community-associated meticillin-resistant
Staphylococcus aureus. Lancet. 375:1557–1568. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Baltch AL, Ritz WJ, Bopp LH, Michelsen PB
and Smith RP: Antimicrobial activities of daptomycin, vancomycin,
and oxacillin in human monocytes and of daptomycin in combination
with gentamicin and/or rifampin in human monocytes and in broth
against Staphylococcus aureus. Antimicrob Agents Chemother.
51:1559–1562. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Dancer SJ: The effect of antibiotics on
methicillin-resistant Staphylococcus aureus. J Antimicrob
Chemother. 61:246–253. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Aqil F, Ahmad I and Owais M: Evaluation of
anti-methicillin-resistant Staphylococcus aureus (MRSA)
activity and synergy of some bioactive plant extracts. Biotechnol
J. 1:1093–1102. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Miranda-Novales G, Leaños-Miranda BE,
Vilchis-Pérez M and Solórzano-Santos F: In vitro activity effects
of combinations of cephalothin, dicloxacillin, imipenem, vancomycin
and amikacin against methicillin-resistant Staphylococcus
spp. strains. Ann Clin Microbiol Antimicrob. 5:252006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kastoris AC, Rafailidis PI, Vouloumanou
EK, Gkegkes ID and Falagas ME: Synergy of fosfomycin with other
antibiotics for Gram-positive and Gram-negative bacteria. Eur J
Clin Pharmacol. 66:359–368. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
López-Lázaro M: Distribution and
biological activities of the flavonoid luteolin. Mini Rev Med Chem.
9:31–59. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lin Y, Shi R, Wang X and Shen HM:
Luteolin, a flavonoid with potential for cancer prevention and
therapy. Curr Cancer Drug Targets. 8:634–646. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Seelinger G, Merfort I and Schempp CM:
Anti-oxidant, anti-inflammatory and anti-allergic activities of
luteolin. Planta Med. 74:1667–1677. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Seelinger G, Merfort I, Wölfle U and
Schempp CM: Anti-carcinogenic effects of the flavonoid luteolin.
Molecules. 13:2628–2651. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Clinical and Laboratory Standards
Institute (CLSI): Methods for dilution antimicrobial susceptibility
tests for bacteria that grow aerobically; approved standard. CLSI
Document M7-A7 (7th). (Wayne, PA, USA). CLSI. 2006.
|
|
16
|
Odds FC: Synergy, antagonism, and what the
chequerboard puts between them. J Antimicrob Chemother. 52:12003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mazumdar K, Dutta NK, Kumar KA and
Dastidar SG: In vitro and in vivo synergism between tetracycline
and the cardiovascular agent oxyfedrine HCl against common
bacterial strains. Biol Pharm Bull. 28:713–717. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Scheuber PH, Mossmann H, Beck G and Hammer
DK: Direct skin test in highly sensitized guinea pigs for rapid and
sensitive determination of staphylococcal enterotoxin B. Appl
Environ Microbiol. 46:1351–1356. 1983.PubMed/NCBI
|
|
19
|
Abate G, Mshana RN and Miörner H:
Evaluation of a colorimetric assay based on
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT)
for rapid detection of rifampicin resistance in Mycobacterium
tuberculosis. Int J Tuberc Lung Dis. 2:1011–1016.
1998.PubMed/NCBI
|
|
20
|
Shi YJ, Chen J and Xu M: A new method for
antimicrobial susceptibility testing of in vitro-cultured bacteria
by means of resonance light scattering technique. J Microbiol
Biotechnol. 18:118–123. 2008.PubMed/NCBI
|
|
21
|
Chang SC, Chen YC, Luh KT and Hsieh WC: In
vitro activities of antimicrobial agents, alone and in combination,
against Acinetobacter baumannii isolated from blood. Diagn
Microbiol Infect Dis. 23:105–110. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roth DM, Senna JP and Machado DC:
Evaluation of the humoral immune response in BALB/c mice immunized
with a naked DNA vaccine anti-methicillin-resistant
Staphylococcus aureus. Genet Mol Res. 5:503–512.
2006.PubMed/NCBI
|
|
23
|
Pearson H: ‘Superbug’ hurdles key drug
barrier. Nature. 418:4692002. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ohwada A, Sekiya M, Hanaki H, Arai KK,
Nagaoka I, Hori S, Tominaga S, Hiramatsu K and Fukuchi Y: DNA
vaccination by mecA sequence evokes an antibacterial immune
response against methicillin-resistant Staphylococcus
aureus. J Antimicrob Chemother. 44:767–774. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Drago L, De Vecchi E, Nicola L and
Gismondo MR: In vitro evaluation of antibiotics' combinations for
empirical therapy of suspected methicillin resistant
Staphylococcus aureus severe respiratory infections. BMC
Infect Dis. 7:1112007. View Article : Google Scholar : PubMed/NCBI
|
